Genetics in diabetic retinopathy: Current concepts and new insights

Current Genomics

Volumn 14, Issue 5, 2013, Pages 289-299

  Simó Servat, Olga ^a   Hernández, Cristina ^a,b   Simó, Rafael ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Diabetic retinopathy; Genetics; Genome wide association studies; Linkage studies

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALDEHYDE REDUCTASE; ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN; VASCULOTROPIN;

ALLELE; CHROMOSOME 17Q; CHROMOSOME 6; CHROMOSOME 7Q; CLINICAL TRIAL (TOPIC); DIABETIC MACULAR EDEMA; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; HYPERGLYCEMIA; HYPOXIA; META ANALYSIS (TOPIC); OSMOTIC STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERSONALIZED MEDICINE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INJURY;

EID: 84882743798     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/13892029113149990008     Document Type: Review

References (96)

1. Stratton, I.M.; Kohner, E.M.; Aldington, S.J.; Turner, R.C.; Hol- man, R.R.; Manley, S.E.; Matthews, D.R. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia, 2001, 44, 156-163.
2. Looker, H.C.; Krakoff, J.; Knowler, W.C.; Bennet, P.H.; Klein, R.; Hanson, RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care, 2003, 26, 320-326.
3. Agardh, E.; Agardh, C.D.; Koul, S.; Torffvit, O. A four-year follow-up study on the incidence of diabetic retinopathy in older onset diabetes mellitus. Diabet. Med., 1994, 11, 273-278.
4. Cohen, O.; Norymberg, K.; Neumann, E.; Dekel, H. Complication-free duration and the risk of development of retinopathy in elderly diabetic patients. Arch. Intern. Med., 1998, 158, 641-644.
5. Yoshida, Y.; Hagura, R.; Hara, Y.; Sugasawa, G.; Akanuma, Y. Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. Diabetes. Res. Clin. Pract., 2001, 51, 195-203.
6. Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes, 1995, 44, 968-983.
7. Stratton, I.M.; Adle, A.I.; Neil, H.A.; Matthews, D.R.; Manley, S.E.; Cull, CA.; Hadden, D.; Turner, R.C.; Holman, R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ., 2000, 321, 405-412.
8. Klein, R.; Klein, B.E.; Moss, S.E.; Davis, M.D.; DeMets, D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 1984, 102, 520-526.
9. Jerneld, B.; Algvere, P. Relationship of duration and onset of diabetes to prevalence of diabetic r.etinopathy. Am. J. Ophtalmol., 1986, 102, 431-437.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New. Engl. J. Med., 1993, 329(14), 977-986.
11. R. Turner. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complica tions in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352(9131), 837-853.
12. Matthews, D.R.; Stratton, I.M.; Aldington, S.J.; Holman, R.R.; Kohner, E.M. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch. Ophthalmol., 2004, 122(11), 1631-1640.
13. Tight blood pressure control and risk of macrovascular and mi-crovascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ, 1998, 217(7160):703-713.
14. Moss, S.E.; Klein, R.; Klein, B.E.K. 10-year incidence of visual loss in a diabetic population. Ophtalmology, 1994, 101, 1061-1070.
15. The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes, 1997, 46, 1829-1839.
16. Patel, A.; MacMahon, S.; Chalmers, J.; Neal, B.; Woodwrd, M.; Billot, L.; Harrap, S.; Poulter, N.; Marre, M.; Cooper, M.; Glasz-iou, P.; Grobbe, D.E.; Hamet, P.; Heller, S.; Liu, L.S.; Mancia, G.; Mogensen, C.E.; Pan, C.Y.; Rodgers, A.; Williams, B. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes melli-tus (the ADVANCE trial): a randomised controlled trial. Lancet, 2007, 370(9590), 829-840.
17. Keenan, H.A.; Costacou, T.; Sun, J.K.; Doria, A.; Cavellerano, J.; Coney, J.; Orchard, T.J.; Aiello, L.P.; King, G.L. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care, 2007, 30(8), 1995-1997.
18. Arar, N.H.; Freedman, BI.; Adler, S.G.; Iyengar, S.K.; Chew, E.Y.; Davis M.D.; Satko, S.G.; Bowden D.W.; Duggirala, R.; Elston R.C.; Guo X.; Hanson, R.L.; Igo, R.P Jr.; Ipp, E.; Kimmel, P.L.; Knowler, W.C.; Molineros, J.; Nelson, R.G.; Pahl, M.V.; Quade, S.R.; Rasooly, R.S., Rotter, J.I.; Saad, M.F.; Scavini, M.; Schelling, J.R.; Sedor, J.R.; Shah, V.O.; Zager, P.G.; Abboud, H.E.; Family Investigation of Nephropathy and Diabetes Research Group. Heri-tability of the severity of diabetic retinopathy: the FIND-Eye study. Invest. Ophthalmol. Vis. Sci., 2008, 49, 3839-3845.
19. Hietala, K.; Forsblom, C.; Summanen, P.; Groop, P.H. Heritability of proliferative diabetic retinopathy. Diabetes, 2008, 57, 2176-2180.
20. Leslie, R.D.; Pyke, D.A. Diabetic retinopathy in identical twins. Diabetes, 1982, 31, 19-21.
21. Rema, M.; Saravanan, G.; Deepa, R.; Mohan, V. Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet. Med., 2002, 19, 910-916.
22. Hallman, D.M.; Huber, J.C Jr.; Gonzalez, VH.; Klein, B.E.; Klein, R.; Hanis, C.L. Familial aggregation of severity of diabetic reti-nopathy in Mexican Americans from Starr County, Texas. Diabetes Care, 2005, 28, 1163-1168.
23. Monti, M.C.; Lonsdale, JT.; Montomoli, C.; Montross, R.; Schlag, E.; Greenberg, D.A. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J. Clin. Endocrinol. Me-tab., 2007, 92, 4650-4655.
24. Emanuele, N.; Sacks, J.; Klein, R.; Reda, D.; Anderson, R.; Duckworth, W.; Abraira, C.; Veterans Affairs Diabetes Trial Group. Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care, 2005, 28(8), 1954-8.
25. Wong, TY.; Klein, R.; Islam, FM.; Cotch, MF.; Folsom, AR.; Klein, BE.; Sharrett, AR.; Shea, S. Diabetic retinopathy in a multiethnic cohort in the United States. Am. J. Ophthalmol., 2006, 141(3), 446-455.
26. Robison, W.G Jr.; Nagata, M.; Laver, N.; Hohman, TC.; Kinoshita, J.H. Diabetic-like retinopathy in rats prevented with an aldose re-ductase inhibitor. Invest. Ophthalmol. Vis. Sci., 1989, 30(11), 2285-2292.
27. Abhary, S.; Burdon, K.P.; Laurie, K.J.; Thorpe, S.; Landers, J.; Goold, L.; Lake, S.; Petrovsky, N.; Craig, J.E. Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility. Diabetes Care, 2010, 33(8), 1834-1836.
28. Abhary, S.; Hewitt, AW.; Burdon, KP.; Craig, J.E. A Systematic Meta-Analysis of Genetic Association Studies for Diabetic Reti-nopathy. Diabetes, 2009, 58, 2137-2147.
29. Kao, Y.L.; Donaghue, K.; Chan, A.; Knight, J.; Silink, M. A novel polimorphysm in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents in type 1 diabetes. Diabetes, 1999, 48, 1338-1340.
30. Penn, JS.; Madan, A.; Caldwell, RB.; Bartoli, M.; Caldwell, RW.; Hartnett, ME. Vascular endothelial growth factor in eye disease. Prog. Retin. Eye Res., 2008, 27, 331-371.
31. Wirostko, B.; Wong, TY.; Simo, R. Vascular endothelial growth factor and diabetic complications. Prog. Retin. Eye Res., 2008, 27, 608-621.
32. Ishida, S.; Shinoda, K.; Kawashima, S.; Oguchi, Y.; Okada, Y.; Ikeda, E. Coexpression of VEGF receptors VEGF-R2 and neu-tropilin-1 in proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2000, 41, 1649-1656.
33. Simo, R.; Carrasco, E.; García-Ramirez, M.; Hernández, C. Angio-genic and antiangiogenic factors in proliferative diabetic retinopa-thy. Curr. Diabetes Rev., 2006, 2(1), 71-96.
34. Vicenti, V.; Cassano, C.; Rocchi, M.; Persico, G. Assigment of the vascular endotelial growth factor gene to human chromosome 6p21.3. Circulation, 1996, 93, 1493-1495.
35. Awata, T.; Inoue, K.; Kurihara, S.; Ohkubo, T.; Watanabe, M.; Inukai, K.; Inoue, I.; Katayama S. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes, 2002, 51(5), 1635-1639.
36. Awata, T.; Kurihara, S.; Takata, N.; Neda, T.; Iizuka, H.; Ohkubo, T.; Osaki, M.; Watanabe, M.; Nakashima, Y.; Inukai, K.; Inoue, I.; Kawasaki, I.; Mori, K.; Yoneya, S.; Katayama, S. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem. Biophys. Res. Commun., 2005, 333(3), 679-685.
37. Yang, Y.; Andresen, B.T.; Yang, K.; Zhang, Y.; Li, X.; Wang, H. Association of vascular endothelial growth factor -634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese. Exp. Biol. Med., 2010, 235(10), 1204-1211.
38. Buraczynska, M.; Ksiazek, P.; Baranowicz-Gaszczyk, I.; Jozwiak, L. Association of the VEGF gene polymorphism with diabetic reti-nopathy in type 2 diabetes patients. Nephrol. Dial. Transplant, 2007, 22(3), 827-832.
39. Vailati, F.B.; Crispim, D.; Sortica, D.A.; Souza, BM.; Brondanim, L.A.; Canani, LH. The C allele of -634G/C polymorphism in the VEGFA gene is associated with increased VEGFA gene expression in human retinal tissue. Invest. Ophthalmol. Vis. Sci., 2012, 53(10), 6411-6415.
40. Fegghi, M.; Nikzamir, A.; Esteghamati, A.; Mahmoudi, T.; Yekaninejad, M.S. Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. Transl. Res., 2011, 158(2), 85-91.
41. Bleda, S.; De Haro, J.; Varela, C.; Esparza, L.; Ferruelo, A.; Acin, F. Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients. Diab. Vasc. Dis. Res., 2012, 9(1), 68-74.
42. Suganthalakshmi, B.; Anand, R.; Kim, R.; Mahalakshmi, R.; Karthikprakash, S.; Namperumalsamy, P.; Sundaresan, P. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol. Vis., 2006, 11(12), 336-341.
43. Uthra, S.; Raman, R.; Mukesh, BN.; Rajkumar, SA.; Padmaja, K.R.; Paul, P.G.; Lakshmipathy, P.; Gnanamoorthy, P.; Sharma, T.; McCarty, C.A.; Kumaramanickavel, G. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic. Genet., 2008, 29(1),11-15.
44. Nakamura, S.; Iwasaki, N.; Funatsu, H.; Kinato, S.; Iwamoto, Y. Impact of variants in the VEGF gene on progression of diabetic retinopathy. Graefes. Arch. Clin. Exp. Ophthalmol., 2009; 247, 21-26.
45. Carter, J.G.; Cherry, J.; Williams, K.; Turner, S.; Bates, D.O.; Churchill, A.J. Splicing factor polymorphisms. The control of VEGF isoforms and association with angiogenic eye disease. Curr. Eye. Res., 2011, 36(4), 328-335.
46. Al-Kateb, H.; Mirea, L.; Xie, X.; Sun, L.; Liu, M.; Chen, H.; Bull, S.B.; Boright, A.P.; Paterson, A.D.; DCCT/EDIC Research Group. Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes, 2007, 56(8), 2161-2168.
47. Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp. Mol. Pathol., 2003, 75(1), 95-108.
48. Goldin A, Beckam J.A, Schmidt A.M, Creager M.A. Advanced glycation en products: sparking the development of diabetic vascular injury. Circulation, 2006, 114(6), 597-605.
49. Schmidt, A.M.; Yan, S.D.; Wautier, JL.; Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res., 1999, 84, 489-497.
50. Lindholm, E.; Bakhtadze, E.; Sjogren, M.; Cilio, C.M.; Agardh, E.; Groop, L.; Agardh, C.D. The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and reti-nopathy in type 1 diabetic patients. Diabetologia, 2006, 49(11), 2745-2755.
51. Ramprasad, S.; Radha, V.; Mathias, RA.; Majumder, P.P.; Rao, M.R.; Rema, M. Rage gene promoter polymoprhisms and diabetic retinopathy in a clinic-based population from South India. Eye, 2007, 21(3), 395-401.
52. Ng, Z.X.; Kuppusamy, U.R.; Tajunisah, I.; Fong, K.C.; Chua, K.H. Association analysis of -429T/C and 374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malasyan with type 2 diabetic retinopathy. Diabetes. Res. Clin. Pract., 2012, 95(3), 372-377.
53. Dos Santos, K.G.; Canani, L.H.; Gross, J.L.; Tschiedel, B.; Pires Souto, K.E.; Roisenberg, I. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic hearts disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab., 2005, 85(2), 149-156.
54. JiXiong, X.; BiLin, X.; MingGong, Y.; ShuQin, L. -479 T/C and -374 T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care, 2003, 26(9), 2696-2697.
55. Glonbocnik Petrovic, M.; Steblovnik, K.; Peterlin, B.; Petrovic, D. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin. Monbl. Augenheilkd., 2003, 220(12), 873-876.
56. Balasubbu, S.; Sundaresan, P.; Rajedran, A.; Ramasamy, K.; Go-vindarajan, G.; Perumalsamy, N.; Hejtmancik, JF. Association of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med. Genet., 2012, 10(11), 158.
57. Zhang, H.M.; Chen, L.L.; Wang, L.; Liao, Y.F.; Wu, Z.H.; Ye, F.; Xu, S.; Yi, L.L. Association of 1704G/T and G28S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. J. Endocrinol. Invest., 2009, 32(3), 258-262.
58. Hudson, B.I.; Stickland, M.H.; Futers, T.S.; Grant, P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes, 2001, 50(6), 1505-1511.
59. Uthra, S.; Raman, R.; Mukesh, B.N.; Rajkumar, S.A.; Kumari, P.; Lakshmiopathy, P.; Gnanamoorthy, P.; Sharma, T.; McCary, CA.; Kumaramanickavel, G. Diabetic retinopathy: Validation study of ALR2, RAGE, iNOS and TNFB gene variants in a south Indian cohort. Ophtalmic. Genet., 2010, 31(4), 244-251.
60. Kang, P.; Tian, C.; Jia, C. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy. Gene, 2012, 500(1), 1-9.
61. Niu, W.; Qi, Y.; Wu, Z.; Liu, Y.; Zhu, D.; Jin, W. A meta-analysis of receptor for advanced glycation end products gene: four well-evaluated polymorphisms with diabetes mellitus. Mol. Cell. Endo-crinol., 2012, 358(1), 9-17.
62. Ng, Z.X.; Kuppusamy, U.R.; Tajunisah, I.; Fong, K.C.; Koay, A.C.; Chua, K.H. 2245G/A polymorphism of the receptor for advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malasyan population. Br. J. Ophthal-mol., 2012, 96(2), 289-292.
63. Sheng, H.; Ignarro, L.J. Biochemical and immunohistochemical characterisation of nitric-oxide synthase in the rat retina. Pharm. Res., 1996, 33, 29-34.
64. Li, Q.; Verna, A.; Han, P.Y.; Nakagawa, T.; Johnson, R.J.; Grant, M.B.; Campbell-Thopmson, M.; Jarajapu, Y.P.; Lei, B.; Hauswirth, W.W. Diabetic eNOS-knockout mice develop accelerated retinopa-thy. Invest. Ophthalmol. Vis. Sci., 2012, 51(10), 5240-5246.
65. Chen, Y.; Huang, H.; Zhou, Jm.; Doumatey, A.; Lashley, K.; Chen, G.; Agyenim-Boateng, K.; Eghan, B.A.; Acheampong, J.; Fasan-made, O.; Johnson, T.; Akinsola, F.B.; Okafor, G.; Oli, J.; Ezepue, F.; Amoah, A.; Akafo, S.; Adeyemo, A.; Rotimi, C.N. Polymo-prhism of the endothelial nictric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol. Vis., 2007, 26(13), 2142-2147.
66. Mamoulakis, D.; Bitsori, M.; Galanakis, E.; Vazgiourakis, V.; Panierakis, C.; Goulielmos, GN. Intron 4 polymorphism of the en-dothelial nictric oxide synthase eNOS gene and early microan-giopathy in type 1 diabetes. Int. J. Immunogenet., 2009, 36(3), 153-157.
67. Santos, K.G.; Crispim, D.; Canani, L.H.; Ferrugem, PT.; Gross, J.L.; Roisenberg, I. Relationship of endothelial nitric oxide syn-thase (eNOS) gene polymorphisms with diabetic retinopathy in Caucasians with type 2 diabetes. Ophtalmic. Genet., 2012, 33(1), 23-27.
68. Bazzaz, J.T.; Amoli, MM.; Pravica, V.; Chanrasecaran, R.; Boul-ton, AJ.; Larijani, B.; Hutchinson, IV. ENOS gene polymorphism association with retinopathy in type 1 diabetes. Ophthalmic. Genet., 2010, 31(3), 103-107.
69. Zhao, S.; Li, T.; Zheng, B.; Zheng, Z. Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis. Ophthalmic. Genet., 2012, 3(4), 200-207.
70. Fletcher, E.L.; Phipps, J.A.; Ward, M.M.; Vessey, K.A.; Wilkin-son-Berka, J.L. The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature. Prog. Retin. Eye Res., 2010, 29(4), 284-311
71. Nikzamir, A.; Rashidi, A.; Esteghamati, A.; Nakhjavani, M.; Gol-mohammadi, T.; Khalilzadeh, O. The relationship between ACE gene insertion/deletion polymorphism and diabetic retinopathy in Iranian patients with type 2 diabetes. Ophthalmic. Genet., 2010, 31(3), 108-113.
72. Feghhi, M.; Nikzamir, A.; Esteghamati, A.; Farahi, F.; Nakhjavani, M.; Rashidi, A. The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative reti-nopathy in type 2 diabetes. Diabetes Res. Clin. Pract., 2008, 81(3), 1-4.
73. Lu, Y.; Ge, Y.; Hu, Q.; Shi, Y.; Xue, C.; Shi, Y.; Chen, S.; Huang, Z. Association between angiotensin-converting enzyme gene polymorphism and diabetic retinopathy in the Chinese population. J. Renin Angiotensin Aldosterone Syst., 2012, 13(2), 289-295.
74. Liang, S.; Pan, M.; Hu, N.; Wu, Y.Y.; Chen, H.; Zhu, J.H.; Guan, H.J.; Sang, A.M. Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population. Mol. Biol. Rep., 2012, 40(1), 463-468.
75. Tong, Z.; Yang, Z.; Patel, S.; Chen, H.; Gibbs, D.; Yang, X.; Hau, V.S.; Kaminoh, Y.; Harmon, J.; Pearson, E.; Buehler, J.; Chen, Y.; Yu, B.; Tinkham, N.H.; Zabriskie, NA.; Zeng, J.; Luo, L.; Sun, J.K.; Prakash, M.; Hamam, R.N.; Tonna, S.; Constantine, R.; Ron-quillo, C.C.; Sadda, S.; Avery, R.L.; Brand, JM.; London, N.; An-duze, A.L.; King, G.L.; Bernstein, P.S.; Watkins, S.; Jorde, L.B.; Li, D.Y.; Aiello, L.P.; Pollak, M.R.; Zhang, K. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc. Natl. Acad. Sci. USA., 2008, 105, 6998-7003.
76. Williams, W.W.; Salem, R.M.; McKnight, A.J.; Sandholm, N.; Forsblom, C.; Taylor, A.; Guiducci, C.; McAteer, J.B.; McKay, G.J.; Isakova, T.; Brennan, E.P.; Sadlier, D.M.; Palmer, C.; Söder-lund, J.; Fagerholm, E.; Harjutsalo, V.; Lithovius, R.; Gordin, D.; Hietala, K.; Kytö, J.; Parkkonen, M.; Rosengård-Bärlund, M.; Thorn, L.; Syreeni, A.; Tolonen, N.; Saraheimo, M.; Wadén, J.; Pitkäniemi, J.; Sarti, C.; Tuomilehto, J.; Tryggvason, K.; Öster-holm, A.M.; He, B.; Bain, S.; Martin, F.; Godson, C.; Hirschhorn, J.N.; Maxwell, A.P.; Groop, P.H.; Florez, J.C.; GENIE Consortium. Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes, 2012, 61(8), 2187-2194.
77. McVicar, CM.; Hamilton, R.; Colhoun, L.M.; Gardiner, T.A.; Brines, M.; Cerami, A.; Stitt, A.W. Intervention with an erythro-poietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes, 2011, 60(11), 2995-3005
78. Hernández, C.; Simó, R. Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy. Endocrine, 2012, 41(2), 220-226
79. Garcia-Ramírez, M.; Hernández, C.; Ruiz-Meana, M.; Villarroel, M.; Corraliza, L.; García-Dorado, D.; Simó, R. Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling. Cell. Signal., 2011, 23(10), 1596-1602.
80. Watanabe, D.; Suzuma, K.; Matsui, S.; Kurimoto, M.; Kiyru, J.; Kita, M.; Suzuma, I.; Ohashi, H.; Ojima, T.; Murakami, T.; Koba-yashi, T.; Masuda, S.; Nagao, M.; Yoshimura, N.; Takagi, H. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med., 2005, 353, 782-792.
81. Paterson, A.D.; Bull, S.B. Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently? J. Cardiovasc. Transl. Res., 2012, 5(4), 388-398.
82. Ma, J.; Li, Y.; Zhou, F.; Xu, X.; Guo, G.; Qu, Y. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-y2 gene and diabetic retinopathy in Caucasians and Asians. Mol. Vis., 2012, 18:2352-2360.
83. Imperatore, G.; Hanson, R.L.; Pettitt, DJ.; Kobes, S.; Bennett, P.H.; Knowler, W.C. Sib-Pair Linkage Analysis for Susceptibility Genes for Microvascular Complications Among Pima Indians With Type 2 Diabetes. Diabetes, 1998, 47(5), 821-830.
84. Looker, HC; Nelson, RG.; Chew, E.; Klein, R.; Klein, BE.; Knowler, WC; Hanson, RL. Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy. Diabetes, 2007, 56(4): 1160-1166.
85. Hallman, D.M.; Boerwinkle, E.; Gonzalez, V.H.; Klein, B.E.; Klein, R.; Hanis,.L. A Genome-Wide Linkage Scan for Diabetic Retinopahty Susceptibility Genes in Mexican Americans With Type 2 diabetes From Starr County, Texas. Diabetes, 2007, 56(4), 1167-1173.
86. Doria, A. Genetics of Diabetes Complications. Curr. Diab. Rep., 2010, 10(6), 467-475.
87. Grassi, M.A.; Tikhomirov, A.; Ramalingam, S.; Below, J.E.; Cox, N.J.; Nicolae, D.L. Genome-wide meta-analysis for severe diabetic retinopathy. Hum. Mol. Genet., 2011, 20(12):2472-2481.
88. Grassi, M.A.; Tikhomirov, A.; Ramalingam, S.; Lee, KE.; Hosseini, S.M.; Klein, B.E.; Klein, R.; Lussier, Y.A.; Cox, N.J.; Nicolae, D.L. Replication analysis for severe diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2012, 53(4), 2377-2381.
89. Musunuru, K.; Lettre, G.; Young, T.; Farlow, D.N.; Pirruccello, J.P.; Ejebe, K.G.; Keating, B.J.; Yang, Q.; Chen, M.H.; Lapchyk, N.; Crenshaw, A.; Ziaugra, L.; Rachupka, A.; Benjamin, E.J.; Cupples, L.A.; Fornage, M.; Fox, E.R.; Heckbert, S.R.; Hirschhorn, J.N.; Newton-Cheh, C; Nizzari, M.M.; Paltoo, D.N.; Papanicolaou, G.J.; Patel, S.R.; Psaty, B.M.; Rader, D.J.; Redline, S.; Rich, S.S.; Rotter, J.I.; Taylor, H.A.Jr.; Tracy, R.P.; Vasan, R.S.; Wilson, J.G.; Kathiresan, S.; Fabsitz, R.R.; Boerwinkle, E.; Gabriel, S.B.; NHLBI Candidate Gene Association Resource. Candidate gene association resource (CARe): design, methods, and proof of concept. Circ. Cardiovasc. Genet., 2010, 3:267-275.
90. Keating, B.J.; Tischfield, S.; Murray, S.S.; Bhangale, T.; Price, T.S.; Glessner, J.T.; Galver, L.; Barrett, J.C.; Grant, S.F.; Farlow, D.N.; Chandrupatla, H.R.; Hansen, M.; Ajmal, S.; Papanicolaou, G.J.; Guo, Y.; Li, M.; Derohannessian, S.; de Bakker, P.I.; Bailey, S.D.; Montpetit, A.; Edmondson, A.C.; Taylor, K.; Gai, X.; Wang, S.S.; Fornage, M.; Shaikh, T.; Groop, L.; Boehnke, M.; Hall, A.S.; Hattersley, A.T.; Frackelton, E.; Patterson, N.; Chiang, C.W.; Kim, C.E.; Fabsitz, R.R.; Ouwehand, W.; Price, A.L.; Munroe, P.; Caulfield, M.; Drake, T.; Boerwinkle, E.; Reich, D.; Whitehead, A.S.; Cappola, T.P.; Samani, N.J.; Lusis, A.J.; Schadt, E.; Wilson, J.G.; Koenig, W.; McCarthy, M.I.; Kathiresan, S.; Gabriel, S.B.; Hakonarson, H.; Anand, S.S.; Reilly, M.; Engert, J.C.; Nickerson, D.A.; Rader, D.J.; Hirschhorn, J.N.; Fitzgerald, G.A. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One, 2008, 3:e3583.
91. Sobrin, L.; Green, T.; Sim, X.; Jensen, R.A.; Tai, E.S.; Tay, W.T.; Wang, J.J.; Mitchell, P.; Sandholm, N.; Liu, Y.; Hietala, K.; Iyengar, S.K.; Brooks, M.; Buraczynska, M.; Van Zuydam, N.; Smith, A.V.; Gudnason, V.; Doney, A.S.; Morris, A.D.; Leese, G.P.; Palmer, C.N.; Swaroop, A.; Taylor, H.A.Jr.; Wilson, J.G.; Penman, A.; Chen, C.J.; Groop, P.H.; Saw, S.M.; Aung, T.; Klein, B.E.; Rotter, J.I.; Siscovick, D.S.; Cotch, M.F.; Klein, R.; Daly, M.J.; Wong, T.Y; Family Investigation of Nephropathy and Diabetes-Eye Research Group Wellcome Trust Case Control Consortium 2. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest. Ophthalmol. Vis. Sci., 2011, 52, 7593-7602.
92. Ntzani, E.E.; Liberopoulos, G.; Manolio, T.A.; Ioannidis, J.P. Consistency of genome-wide associations across major ancestral groups. Hum. Genet., 2012, 131(7), 1057-1071.
93. Zeggini, E.; Rayner, W.; Morris, A.P.; Hattersley, A.T.; Walker, M.; Hitman, G.A.; Deloukas, P.; Cardon, L.R.; McCarthy, M.I. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets. Nat. Genet., 2005, 37, 1320-1322
94. Wang, W.Y.; Barratt, B.J.; Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet. 2005; 6(2):109-118
95. Wong, TY.; Klein, R.; Klein, B.E.; Tielsch, J.M.; Hubbard, L.; Nieto, F.J. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv. Ophthalmol., 2001, 46, 59-80.
96. Jensen, R.A.; Sim, X.; Li, X.; Cotch, M.F.; Ikram, M.K.; Holliday, E.G.; Eiriksdottir, G.; Harris, T.B.; Jonasson, F.; Klein, BE.; Launer, L.J.; Smith, A.V.; Boerwinkle, E.; Cheung, N.; Hewitt, A.W.; Liew, G.; Mitchell, P.; Wang, JJ.; Attia, J.; Scott, R.; Glazer, N.L.; Lumley, T.; McKnight, B.; Psaty, BM.; Taylor, K.; Hofman, A.; de Jong, PT.; Rivadeneira, F.; Uitterlinden, AG.; Tay, W.T.; Teo, YY.; Seielstad, M.; Liu, J.; Cheng, C.Y.; Saw, SM.; Aung, T.; Ganesh, SK.; O'Donnell, C.J.; Nalls, M.A.; Wiggins, K.L.; Kuo, J.Z.; van Duijn C.M, Gudnason V, Klein R, Siscovick D.S, Rotter J.I, Tai ES, Vingerling J, Wong T.Y. Blue Mountains Eye Study GWAS team; CKDGen Consortium. Genome-Wide Association study of Retinopathy in Individuals without Diabetes. PLoS One, 2013, 8(2), e54232.